{"id":224983,"date":"2026-09-01T09:50:17","date_gmt":"2026-09-01T04:20:17","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=224983"},"modified":"2026-09-11T10:56:17","modified_gmt":"2026-09-11T05:26:17","slug":"why-astrazeneca-pharma-india-ltd-share-price-52-week-low-today-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-astrazeneca-pharma-india-ltd-share-price-52-week-low-today-2026\/","title":{"rendered":"Astrazeneca Pharma India Ltd. (ASTRAZEN) Share Price Hits Fresh 52-Week Low"},"content":{"rendered":"<div class=\"univest-blue-summary\" style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:12px 16px;margin:0 0 18px 0;font-style:italic;\"><em><a href=\"https:\/\/univest.in\/stocks\/astrazen\/astrazeneca-pharma-india-ltd-share-price-today\">Astrazeneca Pharma India Ltd. (ASTRAZEN)<\/a> share price fell to a fresh 52-week low of Rs 6,767 today and later stood at Rs 6,773, down 1.25% from the previous close. Market cap was Rs 17,146.63 crore.<\/em><\/div>\n<p style=\"margin-top:0!important;\">Astrazeneca Pharma India Ltd. at Rs 6,773, down 1.25% today, hit a fresh 52-week low of Rs 6,767. Market capitalisation stands at Rs 17,146.63 crore.<\/p>\n<p>Astrazeneca Pharma India Ltd. Share Price fell to Rs 6,773 on 11 September 2026, down 1.25% for the day, after touching a fresh 52-week low of Rs 6,767. The stock\u2019s market capitalisation stands at Rs 17,146.63 crore, placing it among the larger listed names in the Pharmaceuticals &amp; Drugs space. For investors searching Astrazeneca Pharma India Ltd. Share Price Today or Astrazeneca Pharma India Ltd. Stock News, the verified data confirms a new one-year low but does not establish a company-specific catalyst.<\/p>\n<p>The move is drawing attention because the stock opened at Rs 6,858.7, matched its day\u2019s high at Rs 6,858.7, and then slipped to the session low of Rs 6,767 before trading marginally above that level. Turnover was Rs 0.04 crore. From a financial perspective, the company is trading at a P\/E ratio of 101.09 and a P\/B ratio of 18.96, while ROE stands at 23.02 and ROCE at 31.24. On Univest, that combination makes the stock relevant for both price-action watchers and investors comparing valuation against profitability.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/why-astrazeneca-pharma-india-ltd-share-price-52-week-low-today-2026\/#Astrazeneca_Pharma_India_Ltd_Share_Price_Today_Price_Action_Analysis\" title=\"Astrazeneca Pharma India Ltd. Share Price Today: Price Action Analysis\">Astrazeneca Pharma India Ltd. Share Price Today: Price Action Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/why-astrazeneca-pharma-india-ltd-share-price-52-week-low-today-2026\/#Astrazeneca_Pharma_India_Ltd_ASTRAZEN_Fundamental_Analysis\" title=\"Astrazeneca Pharma India Ltd. (ASTRAZEN) Fundamental Analysis\">Astrazeneca Pharma India Ltd. (ASTRAZEN) Fundamental Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/why-astrazeneca-pharma-india-ltd-share-price-52-week-low-today-2026\/#Sector_and_Industry_Context\" title=\"Sector and Industry Context\">Sector and Industry Context<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/why-astrazeneca-pharma-india-ltd-share-price-52-week-low-today-2026\/#Peer_Comparison\" title=\"Peer Comparison\">Peer Comparison<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/why-astrazeneca-pharma-india-ltd-share-price-52-week-low-today-2026\/#Why_Investors_Are_Watching_Astrazeneca_Pharma_India_Ltd\" title=\"Why Investors Are Watching Astrazeneca Pharma India Ltd.\">Why Investors Are Watching Astrazeneca Pharma India Ltd.<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/why-astrazeneca-pharma-india-ltd-share-price-52-week-low-today-2026\/#About_Astrazeneca_Pharma_India_Ltd\" title=\"About Astrazeneca Pharma India Ltd.\">About Astrazeneca Pharma India Ltd.<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/why-astrazeneca-pharma-india-ltd-share-price-52-week-low-today-2026\/#Track_Astrazeneca_Pharma_India_Ltd_Share_Price_on_Univest\" title=\"Track Astrazeneca Pharma India Ltd. Share Price on Univest\">Track Astrazeneca Pharma India Ltd. Share Price on Univest<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/why-astrazeneca-pharma-india-ltd-share-price-52-week-low-today-2026\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/why-astrazeneca-pharma-india-ltd-share-price-52-week-low-today-2026\/#Why_is_Astrazeneca_Pharma_India_Ltd_Share_Price_in_focus_today\" title=\"Why is Astrazeneca Pharma India Ltd. Share Price in focus today?\">Why is Astrazeneca Pharma India Ltd. Share Price in focus today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/why-astrazeneca-pharma-india-ltd-share-price-52-week-low-today-2026\/#What_is_the_latest_Astrazeneca_Pharma_India_Ltd_Share_Price_Today\" title=\"What is the latest Astrazeneca Pharma India Ltd. Share Price Today?\">What is the latest Astrazeneca Pharma India Ltd. Share Price Today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/why-astrazeneca-pharma-india-ltd-share-price-52-week-low-today-2026\/#Did_Astrazeneca_Pharma_India_Ltd_hit_a_fresh_52-week_low\" title=\"Did Astrazeneca Pharma India Ltd. hit a fresh 52-week low?\">Did Astrazeneca Pharma India Ltd. hit a fresh 52-week low?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/why-astrazeneca-pharma-india-ltd-share-price-52-week-low-today-2026\/#How_much_did_Astrazeneca_Pharma_India_Ltd_fall_today\" title=\"How much did Astrazeneca Pharma India Ltd. fall today?\">How much did Astrazeneca Pharma India Ltd. fall today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/why-astrazeneca-pharma-india-ltd-share-price-52-week-low-today-2026\/#What_does_the_current_price_action_show_for_Astrazeneca_Pharma_India_Ltd\" title=\"What does the current price action show for Astrazeneca Pharma India Ltd.?\">What does the current price action show for Astrazeneca Pharma India Ltd.?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/why-astrazeneca-pharma-india-ltd-share-price-52-week-low-today-2026\/#What_is_the_market_capitalisation_of_Astrazeneca_Pharma_India_Ltd\" title=\"What is the market capitalisation of Astrazeneca Pharma India Ltd.?\">What is the market capitalisation of Astrazeneca Pharma India Ltd.?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/why-astrazeneca-pharma-india-ltd-share-price-52-week-low-today-2026\/#Is_Astrazeneca_Pharma_India_Ltd_expensive_compared_with_its_industry\" title=\"Is Astrazeneca Pharma India Ltd. expensive compared with its industry?\">Is Astrazeneca Pharma India Ltd. expensive compared with its industry?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/why-astrazeneca-pharma-india-ltd-share-price-52-week-low-today-2026\/#How_strong_are_Astrazeneca_Pharma_India_Ltd_profitability_ratios\" title=\"How strong are Astrazeneca Pharma India Ltd. profitability ratios?\">How strong are Astrazeneca Pharma India Ltd. profitability ratios?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/why-astrazeneca-pharma-india-ltd-share-price-52-week-low-today-2026\/#What_are_the_key_earnings_metrics_for_Astrazeneca_Pharma_India_Ltd\" title=\"What are the key earnings metrics for Astrazeneca Pharma India Ltd.?\">What are the key earnings metrics for Astrazeneca Pharma India Ltd.?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/why-astrazeneca-pharma-india-ltd-share-price-52-week-low-today-2026\/#How_does_Astrazeneca_Pharma_India_Ltd_compare_with_peers\" title=\"How does Astrazeneca Pharma India Ltd. compare with peers?\">How does Astrazeneca Pharma India Ltd. compare with peers?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Astrazeneca_Pharma_India_Ltd_Share_Price_Today_Price_Action_Analysis\"><\/span><strong>Astrazeneca Pharma India Ltd. Share Price Today: Price Action Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 6,773<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 6,858.65<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Move<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs -85.65 (-1.25%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 6,858.7<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 6,858.7<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 6,767<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Turnover<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 0.04 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 17,146.63 crore<\/td>\n<\/tr>\n<\/table>\n<p>Astrazeneca Pharma India Ltd. (ASTRAZEN) traded at Rs 6,773 versus the previous close of Rs 6,858.65, a fall of 1.25%. The stock opened at Rs 6,858.7, reached a high of Rs 6,858.7, touched a low of Rs 6,767.<\/p>\n<p>Astrazeneca Pharma India Ltd. Share Price Today reflects a clear intraday slide from the opening zone to a fresh yearly low, with the stock remaining close to the lower end of the day\u2019s range. That makes this a confirmed 52-week trough event, not just a routine decline, and explains why the stock is appearing in market searches and Stock Market Today screens.<\/p>\n<p>The stock closed previously at Rs 6,858.65 and is currently at Rs 6,773, a decline of Rs 85.65 or 1.25%. It opened at Rs 6,858.7, which also marked the day\u2019s high, while the day\u2019s low was Rs 6,767, the same as the new 52-week low. That sequence suggests the session weakened after the open rather than recovering into strength. Turnover at Rs 0.04 crore shows a modest traded value backdrop to the move, while the market cap remains Rs 17,146.63 crore.<\/p>\n<p>For readers tracking Astrazeneca Pharma India Ltd. Share News or Astrazeneca Pharma India Ltd. Share Price Live, the immediate takeaway is straightforward: the stock has broken to a fresh one-year low and is still trading below the opening level. In the absence of a verified catalyst in the supplied data, the price event itself is the confirmed reason the stock is trending in today\u2019s Market News. That brings the focus to valuation, profitability and industry comparisons rather than a headline-driven explanation.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Astrazeneca_Pharma_India_Ltd_ASTRAZEN_Fundamental_Analysis\"><\/span><strong>Astrazeneca Pharma India Ltd. (ASTRAZEN) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 17,146.63 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">101.09x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">18.96x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">23.02%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">31.24%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>EPS<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 67.85<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Book Value Per Share<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 361.68<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Dividend Yield<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0.52%<\/td>\n<\/tr>\n<\/table>\n<p>Astrazeneca Pharma India Ltd. (ASTRAZEN) fundamental metrics show P\/E 101.09x, P\/B 18.96x, ROE 23.02%, ROCE 31.24%. These figures provide context only and are not a buy or sell signal.<\/p>\n<p>Astrazeneca Pharma India Ltd. has a market capitalisation of Rs 17146.63 crore, which gives readers a sense of company size before judging valuation. On valuation, P\/E at 101.09x, P\/B at 18.96x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 23.02% and ROCE of 31.24%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 67.85, book value per share of Rs 361.68, dividend yield of 0.52%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P\/E of 32.42x, median ROE of 11.8%, median ROCE of 13.66%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Industry<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Pharmaceuticals &amp; Drugs<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same industry<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">101.09x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">32.42x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">48.79x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.4x to 701.57x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">18.96x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.04x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">23.02%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.8%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">31.24%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.66%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 17,146.63 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 715.37 crore<\/td>\n<\/tr>\n<\/table>\n<p>Astrazeneca Pharma India Ltd. (ASTRAZEN) is classified under sector: Healthcare and industry: Pharmaceuticals &amp; Drugs.<\/p>\n<p>Astrazeneca Pharma India Ltd. (ASTRAZEN) has a P\/E ratio of 101.09x, which is above the benchmark median of 32.42x, a difference of +211.81%. P\/E is a valuation multiple and is not, by itself, a buy or sell signal.<\/p>\n<p>Astrazeneca Pharma India Ltd. (ASTRAZEN) has a ROE of 23.02%, which is above the benchmark median of 11.8%, a difference of +95.08%. Astrazeneca Pharma India Ltd. (ASTRAZEN) has a ROCE of 31.24%, which is above the benchmark median of 13.66%, a difference of +128.7%.<\/p>\n<p>Track stocks falling to yearly lows through the <a href=\"https:\/\/univest.in\/screeners\/52-week-low\">Univest 52-week-low screener<\/a>. The peer table below provides the company-level comparison.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/alivus\/glenmark-life-sciences-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Glenmark Life Sciences Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">ALIVUS<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">17,087.94<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">28.34<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4.9<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">18.41<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">24.61<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/cohance\/suven-pharmaceuticals-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Suven Pharmaceuticals Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">COHANCE<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16,949.06<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">160.51<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4.43<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4.02<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">6.12<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/jublpharma\/jubilant-pharmova-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Jubilant Pharmova Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">JUBLPHARMA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16,230.75<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">46.4<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2.29<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">5.97<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">8.69<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/aplltd\/alembic-pharmaceuticals-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Alembic Pharmaceuticals Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">APLLTD<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16,074.93<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">23.16<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2.75<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">12.35<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">11.74<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/eris\/eris-lifesciences-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Eris Lifesciences Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">ERIS<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">18,505.72<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">29.16<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4.66<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.23<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.47<\/td>\n<\/tr>\n<\/table>\n<p>Astrazeneca Pharma India Ltd. (ASTRAZEN) has a P\/E ratio of 101.09x compared with the displayed peer median of 29.16x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 23.02% compares with a peer median of 12.35% across the companies shown in the table. ROCE stood at 31.24% versus the displayed peer median of 11.74%, providing a capital-efficiency comparison. Astrazeneca Pharma India Ltd. (ASTRAZEN) has a market capitalisation of Rs 17,146.63 crore. Among the 5 peers shown, 1 have a larger market capitalisation.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_Astrazeneca_Pharma_India_Ltd\"><\/span><strong>Why Investors Are Watching Astrazeneca Pharma India Ltd.<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>The stock touched a fresh 52-week low of Rs 6,767 and was trading at Rs 6,773, down 1.25% on the day.<\/li>\n<li>The session high matched the opening price of Rs 6,858.7, while the stock weakened toward the day\u2019s low.<\/li>\n<li>Valuation remains elevated with a P\/E of 101.09 and P\/B of 18.96.<\/li>\n<li>Profitability metrics are stronger, with ROE at 23.02 and ROCE at 31.24.<\/li>\n<li>Within the same-industry benchmark of 199 companies, the stock trades above median valuation but above median return ratios too.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"About_Astrazeneca_Pharma_India_Ltd\"><\/span><strong>About Astrazeneca Pharma India Ltd.<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Astrazeneca Pharma India Ltd. operates in the Healthcare sector and the Pharmaceuticals &amp; Drugs industry. In listed-market terms, it is a sizeable pharmaceutical company with a market capitalisation of Rs 17,146.63 crore, placing it well above the same-industry median market cap of Rs 715.37 crore. The available data set does not add product-level or segment-level revenue details, but it does place the company firmly within India\u2019s pharmaceutical and healthcare ecosystem.<\/p>\n<p>Its recent financial profile shows meaningful scale, with quarterly revenue figures of Rs 5,263.1 crore, Rs 5,590.9 crore, Rs 6,115.7 crore, Rs 5,786.1 crore and Rs 6,827.9 crore across the latest supplied sequence from Jun 2025 to Jun 2026. The same sequence shows net profit of Rs 558.3 crore, Rs 542.2 crore, Rs 325.9 crore, Rs 448.8 crore and Rs 379.3 crore. On Univest, that makes Astrazeneca Pharma India Ltd. Company News relevant not only for daily price action but also for how the market values those financial outcomes.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Track_Astrazeneca_Pharma_India_Ltd_Share_Price_on_Univest\"><\/span><strong>Track Astrazeneca Pharma India Ltd. Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use <a href=\"https:\/\/univest.in\/stocks\/astrazen\/astrazeneca-pharma-india-ltd-share-price-today\">Astrazeneca Pharma India Ltd. (ASTRAZEN) live share-price page<\/a>, <a href=\"https:\/\/univest.in\/screeners\/52-week-low\">Univest 52-week-low screener<\/a>, <a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, yearly-low lists and related market analysis.<\/p>\n<p>On Univest, investors can track Astrazeneca Pharma India Ltd. Share Price, Astrazeneca Pharma India Ltd. Share Price Today, 52-week levels, market cap, valuation ratios, profitability metrics and peer positioning in one place. Univest also helps users follow Astrazeneca Pharma India Ltd. Latest News, Astrazeneca Pharma India Ltd. Stock Performance and sector-level comparisons across Healthcare and Pharmaceuticals &amp; Drugs. For readers monitoring Share Market Today, Univest provides a structured way to watch price action without turning a single day\u2019s move into a prediction.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Why_is_Astrazeneca_Pharma_India_Ltd_Share_Price_in_focus_today\"><\/span><strong>Why is Astrazeneca Pharma India Ltd. Share Price in focus today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Astrazeneca Pharma India Ltd. Share Price is in focus because the stock touched a fresh 52-week low of Rs 6,767 and traded at Rs 6,773, down 1.25% from the previous close of Rs 6,858.65.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_latest_Astrazeneca_Pharma_India_Ltd_Share_Price_Today\"><\/span><strong>What is the latest Astrazeneca Pharma India Ltd. Share Price Today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The latest Astrazeneca Pharma India Ltd. Share Price Today is Rs 6,773. During the session, the stock opened at Rs 6,858.7, touched a high of Rs 6,858.7 and a low of Rs 6,767.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Did_Astrazeneca_Pharma_India_Ltd_hit_a_fresh_52-week_low\"><\/span><strong>Did Astrazeneca Pharma India Ltd. hit a fresh 52-week low?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Yes, the stock hit a fresh 52-week low of Rs 6,767 on 11 September 2026. It was trading at Rs 6,773 afterward, confirming a new one-year low in the current session.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_much_did_Astrazeneca_Pharma_India_Ltd_fall_today\"><\/span><strong>How much did Astrazeneca Pharma India Ltd. fall today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Astrazeneca Pharma India Ltd. fell by Rs 85.65 in today\u2019s session, a decline of 1.25%. The move came from a previous close of Rs 6,858.65 to a current price of Rs 6,773.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_does_the_current_price_action_show_for_Astrazeneca_Pharma_India_Ltd\"><\/span><strong>What does the current price action show for Astrazeneca Pharma India Ltd.?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The day\u2019s price action shows weakness after the open. The stock opened at Rs 6,858.7, which was also the session high, and then slipped to Rs 6,767 before trading slightly above that low.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_market_capitalisation_of_Astrazeneca_Pharma_India_Ltd\"><\/span><strong>What is the market capitalisation of Astrazeneca Pharma India Ltd.?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Astrazeneca Pharma India Ltd. has a market capitalisation of Rs 17,146.63 crore. That is above the same-industry median of Rs 715.37 crore and also higher than the industry average of Rs 14,192.13 crore.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Astrazeneca_Pharma_India_Ltd_expensive_compared_with_its_industry\"><\/span><strong>Is Astrazeneca Pharma India Ltd. expensive compared with its industry?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Based on supplied benchmarks, the stock trades at a P\/E of 101.09 versus the same-industry median of 32.42 and average of 48.79. Its P\/B of 18.96 also exceeds the median 3.04 and average 4.35.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_strong_are_Astrazeneca_Pharma_India_Ltd_profitability_ratios\"><\/span><strong>How strong are Astrazeneca Pharma India Ltd. profitability ratios?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The company\u2019s ROE is 23.02 and ROCE is 31.24. Both are above the same-industry medians of 11.8 and 13.66, indicating stronger reported returns than many companies in Pharmaceuticals &amp; Drugs.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_key_earnings_metrics_for_Astrazeneca_Pharma_India_Ltd\"><\/span><strong>What are the key earnings metrics for Astrazeneca Pharma India Ltd.?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The supplied data shows EPS at Rs 67.85, book value per share at Rs 361.68 and dividend yield at 0.52. These metrics help frame earnings power, accounting net worth and historical payout relative to price.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Astrazeneca_Pharma_India_Ltd_compare_with_peers\"><\/span><strong>How does Astrazeneca Pharma India Ltd. compare with peers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Astrazeneca Pharma India Ltd. has a market cap close to Glenmark Life Sciences and Suven Pharmaceuticals, but its P\/E of 101.09 is above Glenmark, Jubilant, Alembic and Eris, while ROE and ROCE are stronger than several peers.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Astrazeneca Pharma India Ltd. Share Price hits a new 52-week low at Rs 6,773, marking a 1.25% decline today. Market cap stands at Rs 17,146.63 crore.<\/p>\n","protected":false},"author":29,"featured_media":243287,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-224983","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["243287"],"rank_math_title":["Astrazeneca Pharma India Ltd. Share Price at 52-Week Low"],"rank_math_description":["Astrazeneca Pharma India Ltd. Share Price hit a fresh 52-week low at Rs 6,767. Check price action, valuation, sector benchmark and peer analysis."],"rank_math_focus_keyword":["Astrazeneca Pharma India Ltd. Share Price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/09\/Astrazeneca_Pharma_India_Ltd_ASTRAZEN_Share_Price_Hits_Fresh_52_Week_Low_bearish-3.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/224983","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=224983"}],"version-history":[{"count":4,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/224983\/revisions"}],"predecessor-version":[{"id":243288,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/224983\/revisions\/243288"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/243287"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=224983"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=224983"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=224983"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}